Asset Manager

Updated:

Aravis

Aravis manages buyout and venture capital strategies from Zurich.

Aravis logo

Aravis

Aravis BioTech develops implanted medical devices for the healthcare sector. The company offers devices with sensors to monitor fracture healing status, providing additional imaging for physician assessments. Founded in 2001, Aravis BioTech is based in Greenville, South Carolina.

General information

Firm type

Generalist

Year founded

AUM

Undisclosed

Location

Region

Europe

Country

Switzerland

City

Zurich

Corporate office

Zurich, Switzerland

Frequently asked questions

What stages does Aravis target?

The firm covers buyout alongside early stage seed, start-up, expansion, late stage and growth.

Does Aravis commit to external funds or make direct investments?

Available records list both buyout and venture strategies without specifying fund commitments versus direct deals.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Zurich Generalist profiles